FORTRESS BIOTECHPRFA (Germany) Today
| CNB0 Stock | EUR 4.50 0.04 0.88% |
PerformanceVery Weak
| Odds Of DistressQuite High
|
FORTRESS BIOTECHPRFA is trading at 4.50 as of the 21st of April 2025. This is a 0.88% down since the beginning of the trading day. The stock's lowest day price was 4.34. FORTRESS BIOTECHPRFA has more than 68 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 21st of January 2025 and ending today, the 21st of April 2025. Click here to learn more.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. More on FORTRESS BIOTECHPRFA 25
Moving together with FORTRESS Stock
| 0.65 | NOVA | Novo Nordisk AS | PairCorr |
| 0.82 | CSJA | CSL LTD SPONADR | PairCorr |
| 0.83 | CSJ | CSL Limited | PairCorr |
| 0.83 | 0QF | Moderna | PairCorr |
Moving against FORTRESS Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
FORTRESS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. FORTRESS BIOTECHPRFA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding FORTRESS BIOTECHPRFA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Biotechnology, Healthcare, Computing (View all Sectors) |
FORTRESS BIOTECHPRFA 25 (CNB0) is traded on Frankfurt Exchange in Germany and employs 173 people. The company operates under Healthcare sector and is part of Biotechnology industry.
FORTRESS BIOTECHPRFA 25 has accumulated about 289.9 M in cash with (83.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98.
Check FORTRESS BIOTECHPRFA Probability Of Bankruptcy
Ownership AllocationRoughly 98.2 percent of FORTRESS BIOTECHPRFA outstanding shares are held by general public with 1.8 % by other corporate entities.
Check FORTRESS Ownership Details
FORTRESS BIOTECHPRFA Risk Profiles
Although FORTRESS BIOTECHPRFA's alpha and beta are two of the key measurements used to evaluate FORTRESS BIOTECHPRFA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.0 | |||
| Standard Deviation | 4.13 | |||
| Variance | 17.02 | |||
| Risk Adjusted Performance | (0.18) |
FORTRESS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in FORTRESS BIOTECHPRFA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Other Information on Investing in FORTRESS Stock
FORTRESS BIOTECHPRFA financial ratios help investors to determine whether FORTRESS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FORTRESS with respect to the benefits of owning FORTRESS BIOTECHPRFA security.